Evidence-based skin preparation system

October 2011
CAREFUSION understands that infection prevention is the key to reducing healthcare associated infections (HCAIs). The company helps customers to improve patient care by working in close partnership with hospitals to protect both the operating team and patients through the provision of clinically proven infection prevention products.

With innovative healthcare products and a worldwide support network, CareFusion is a global corporation serving the healthcare industry with some of the most widely recognised products and services.

Patient’s skin dwelling bacteria are the major source of infections associated with medical and surgical invasive procedures. Normally ‘harmless’, these bacteria live in the top five cell layers of the skin and can enter the bloodstream whenever the integrity of the skin is breached - for example in surgery.

While hand washing and appropriate environmental cleaning are essential to the prevention of cross-contamination and limiting the spread of MRSA, the patient and their skin should not be left out of the prevention equation. Blood stream and surgical site infections remain a significant burden to the NHS, patients and their families. The use of all appropriate, evidence based measures to prevent the avoidable infections is paramount.

ChloraPrep is the only licensed and evidence-based skin preparation system that meets the new Department of Health High Impact Intervention to prevent surgical site infection. The 2% Chlorhexidine concentration is now proven in 39 outcome studies and recommended in 12 evidence-based guidelines.
ChloraPrep is a medicinal product containing a solution of 2% chlorhexidine gluconate (w/v) in 70% isopropyl alcohol (v/v) and is a licensed, single use, sterile, ‘non-touch’ skin antisepsis system available in both clear and tint in a variety of sized applicators. ChloraPrep is applied with a gentle back and forth motion for 30 seconds then allowed to air dry completely prior to invasive procedures.


Search